Born in Honolulu, Hawaii, Wily began his professional career as an MMA fighter and sumo wrestler before deciding to pursue acting.
At the age of 56, Taylor Wily, best known for his parts in Magnum P.I. and Hawaii Five-0, passed away.
On Thursday, June 20, Hawaiian artist and celebrity Lina Girl Langi, who had been close friends with Wily and his family, revealed the news of his passing on her lifestyle program Island Life Live.
Langi said on the show, “It is with a heavy heart that I share the news of the passing of a Hawaii celebrity who was also a family friend.” “Taylor Wily, actor, MMA fighter, and former wrestler, passed away in Hurricane, Utah, today.”
Davey D, her co-host, called Wily one of the “kindest” and “gentlest souls.”
Langi did not reveal Willy’s cause of death. She did point out that despite having an intimidating build, the actor was not scary in real life.
She said, “He would appear physically menacing until you simply folded into an embrace, and that was that.” “My heart is shattered.”
According to his IMDb page, Wily began his career as a sumo wrestler under the name “Takamishu” after being born in Honolulu, Hawaii in 1968. He won his first fourteen matches, according to TV Insider, and went on to become the first wrestler not born in the United States to win the title in the third-tier Makushita division.
He then participated in the inaugural Ultimate Fighting Championship event in 2000, losing to fellow fighter Gerard Gordeau and making history as the first competitor to lose in a UFC brawl.
Wily eventually made the transition to acting, starting out in the 1980s and early 2000s with background parts in television series like North Shore, One West, and the original Magnum P.I.
After that, he starred in the movies Radical and Forgetting Sarah Marshall, and on Hawaii Five-0, he was cast as Kamekona, a series regular. In total, 171 episodes of the 2010–2020 season of the show included him. In the Magnum P.I. reboot, he also played the same character again.
On social media, a number of Wily’s acquaintances and admirers offered their condolences to his wife Halona Wily and the rest of his family. Executive producer Peter Lenkov of Magnum P.I. and Hawaii Five-0 also honored the star on Instagram by posting a picture of the two of them together on set.
“I’m inconsolable. Brokenhearted. In a few days, I’ll share some in-depth feelings. Just too difficult at this time,” he wrote.
On Facebook, former Hawaii news reporter Angela Keen wrote that Wily was always “accessible and personable” and had frequently visited kids at Shriners Children’s Hawaii Hospital.
She remarked, “You were the very definition of a gentle giant.” “Taylor Wily, I can’t believe you’re gone.”
After posting a picture of the two, Dennis Chun, who portrayed Sgt. Duke Lukela in the Hawaii Five-0 revival, added, “Laura and I are heart broken to learn of Taylor Wily’s passing.” He was a giant of a man in addition to being a gifted artist.
“Being in a scene with him was always such a joy because of his aloha and heart,” he continued. It was a privilege to work with him and have him as a friend. Taylor, get some rest. Hawaii and I cry this evening. Taylor, till we cross paths again, aloha.
Meet Twins with the Rare Benjamin Button Syndrome, Who Became Symbols of Resilience
In a small Brazilian town, there resides an extraordinary duo of identical twins named Elis and Eloá. Their story serves as a beacon of resilience and the remarkable power of the human spirit. Afflicted with Hutchinson-Gilford Progeria Syndrome, a rare and fatal genetic disorder causing accelerated aging, these twins confront their adversities with remarkable grace and strength, earning admiration from people worldwide.
Understanding Hutchinson-Gilford Progeria syndrome
HGPS stands as an exceptionally rare disorder, impacting roughly 1 in 20 million newborns globally. Marked by rapid aging from early childhood, individuals with progeria often display growth delays, diminished body fat and hair, prematurely aged skin, joint stiffness, and severe cardiovascular issues. Typically, those with HGPS have an average life expectancy of about 14.5 years, though some may extend into their late teens or early twenties. This syndrome gained public attention through the film The Curious Case of Benjamin Button.
The condition is caused by a mutation in the LMNA gene, which produces the lamin A protein responsible for maintaining the structural integrity of the cell nucleus. The mutation results in the production of an abnormal version of the protein, called progerin, which causes cells to become unstable and die prematurely.
Elis and Eloá’s journey
Elis and Eloá swiftly captured attention because of their distinctive medical condition. Despite the physical hurdles imposed by progeria, their contagious smiles and steadfast optimism have emerged as beacons of hope and inspiration. Guilherme and Elismar, the twins’ parents, have dedicated their lives to offering the utmost care for their daughters, striving to ensure they experience as normal a life as feasible within the confines of their condition.
The family’s path has been far from easy. Their daily life is filled with demanding medical routines, including physiotherapy, aimed at addressing joint stiffness and preserving mobility. Despite these challenges, Elis and Eloá approach each day with remarkable bravery and an unparalleled enthusiasm for life, which is truly remarkable.
A global community of support
Elis and Eloá’s narrative has touched hearts worldwide, sparking a surge of solidarity from individuals and groups committed to promoting awareness about progeria and backing research endeavors. The Progeria Research Foundation, a pivotal entity in this realm, has played a vital role in propelling research forward and furnishing assistance to families grappling with the condition.
Through social media platforms, the twins’ journey is shared with a broad audience, fostering a sense of community and solidarity. Their family’s updates, documenting both the highs and lows of their daily lives, provide invaluable insights into the realities of living with progeria, while also spreading a message of hope and perseverance.
Advances in research and hope for the future
In recent years, there have been remarkable advancements in comprehending and addressing progeria. A notable milestone occurred in 2020 when the U.S. Food and Drug Administration (FDA) granted approval for the first progeria treatment: lonafarnib. This medication has demonstrated efficacy in prolonging the lives of children with progeria by mitigating the accumulation of progerin in cells, thereby decelerating the disease’s advancement.
Though a cure remains elusive, ongoing research presents promising prospects. Scientists are delving into gene-editing methodologies, like CRISPR, as potential means to rectify the genetic mutation at its root. For families such as Elis and Eloá’s, these breakthroughs offer a ray of hope for the future.
And in our other article, we recounted the remarkable story of a girl born without a nose, affectionately dubbed “Voldemort,” who refuses to let her differences define her.
Leave a Reply